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1. Introduction
Since its inception two decades ago (in 1996, [1]), the ultra
high-risk (hereafter UHR) state for psychosis quickly became
increasingly inﬂuential in the ﬁeld of psychiatry. The UHR state is
deﬁned on the basis of three inclusion criteria which have been
validated internationally [2]: attenuated psychotic symptoms
(APS), brief and limited intermittent psychotic symptoms (BLIPS)
and genetic risk and deterioration syndrome (GRD) [3]. This has led
to specialist UHR care provision being recognized as an important
component of clinical services for early psychosis intervention
[4,5] (e.g. NICE guidelines [6]; recent NHS England Access and
Waiting Time [AWT] standard [4], DSM-5 diagnostic manual)
[7]. Accumulating evidence has conﬁrmed that help-seeking
individuals meeting UHR criteria have an enhanced risk of
developing psychotic disorders – mostly schizophrenia spectrum
disorders [8] – within a relatively short period of time. The
transition to psychosis in UHR individuals is most likely to occur
within the ﬁrst 2 years after presentation to clinical services, with
25% of transitions occurring by 106 days and 50% by 240 days
[9,10]. The risk of transition to psychosis accumulates to 29% (95%
CI, 23–36) at 2 years [11]. After this phase, the speed of psychosis
progression tends to plateau from the third year, reaching
approximately 35% after 10 years [11]. This risk is signiﬁcantly
higher than the risk of psychosis of 0.0317 per 100 person-years
European Psychiatry 40 (2017) 65–75
A R T I C L E I N F O
Article history:
Received 6 August 2016
Received in revised form 13 September 2016
Accepted 15 September 2016
Available online
Keywords:
Psychosis
Schizophrenia
UHR
ARMS
Prevention
Meta-analysis
A B S T R A C T
Background: Subjects at ultra high-risk (UHR) for psychosis have an enhanced vulnerability to develop the
disorder but the risk factors accounting for this accrued risk are undetermined.
Method: Systematic review of associations between genetic or environmental risk factors for psychosis
that are widely established in the literature and UHR state, based on comparisons to controls.
Results: Forty-four studies encompassing 170 independent datasets and 54 risk factors were included.
There were no studies on association between genetic or epigenetic risk factors and the UHR state that
met the inclusion criteria. UHR subjects were more likely to show obstetric complications, tobacco use,
physical inactivity, childhood trauma/emotional abuse/physical neglect, high perceived stress,
childhood and adolescent low functioning, affective comorbidities, male gender, single status,
unemployment and low educational level as compared to controls.
Conclusions: The increased vulnerability of UHR subjects can be related to environmental risk factors like
childhood trauma, adverse life events and affective dysfunction. The role of genetic and epigenetic risk
factors awaits clariﬁcation.
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(95% CI: 0.025–0.041) [12] observed in the general population.
Consequently, UHR individuals have a 2-year relative risk (RR) for
developing psychosis of 460, as compared to the general
population (29%/0.063%). The risk is higher even when restricting
the comparison to UHR subjects meeting only attenuated
psychosis symptoms (APS) criteria, which have a 2-year risk of
transition of 0.16 (95% CI 0.13–0.19 [3], RR = 254). There is also
converging evidence suggesting that the APS and the BLIPS
subgroups of the UHR show an increased risk of psychosis as
compared to subjects seeking help at clinical services but not
meeting UHR criteria (i.e. UHR) [3]. Conversely, there is no
evidence indicating that UHR individuals are at risk of developing
other non-psychotic disorders. Although a substantial proportion
those not developing psychosis would present with persistent
symptoms or associated comorbid disorders [13], the vast majority
of these problems had already been present at baseline
[14,15]. Furthermore, understanding whether the UHR status
delineates speciﬁc risk for developing non-psychotic mental
disorders necessarily relies upon the comparing of incident rates
of non-psychotic mental disorders in UHR versus a control group
not at risk for psychosis. The only available study conﬁrmed that,
compared to a control group, UHR individuals are not at higher risk
of developing non-psychotic mental disorders [16].
The risk factors accounting for such substantial risk accumu-
lation (RR = 460) are undetermined. The most validated model to
understand the aetiology of psychosis is based on genetic and
environmental risk factors and their interaction [17], likely
involving epigenetic mechanisms [18]. Because UHR individuals
are at enhanced risk of psychosis but not of non-psychotic
disorders, the current review focus on risk factors for psychosis
that have been widely established in the available literature.
According to these premises, UHR individuals are likely to show a
heightened vulnerability because of accumulating genetic and/or
environmental risk factors for psychosis. Indeed, several original
studies have investigated the association of established risk
factors for psychosis and the UHR state. However, the ﬁndings
are sparse and often conﬂicting. For example, some studies
showed that UHR individuals have been more exposed to
traumatic events than controls [19,20], while others found no
differences [21].
To address these inconsistencies and to improve current
knowledge of risk enrichment in the UHR state, this systematic
review investigates the association of established genetic and
environmental risk factors for psychosis and the UHR state. We
ﬁrst test the hypothesis that these risk factors are more likely to
affect UHR individuals, compared to control groups, accounting for
increased vulnerability to psychosis observed in these samples,
compared to controls (RR = 460). We then investigate the speciﬁc
impact of each risk factor by providing a quantitative analysis of
the strength of the association between speciﬁc risk factors for
psychosis and the UHR state.
2. Materials and methods
2.1. Search strategy
Two independent investigators (SDS, MT) conducted two-step
literature searches. First, the Web of KnowledgeSM database was
searched, incorporating both the Web of ScienceSM and
Medline1. The search was extended until 1st of June 2016,
including English language abstracts only. The electronic database
searches used several combinations of the search terms ‘‘UHR’’,
‘‘psychosis risk’’, ‘‘ultra high risk’’, ‘‘at risk mental state’’,
‘‘subclinic* psychosis’’, ‘‘earl* psychosis’’, ‘‘prodrom* psychosis’’,
‘‘psychosis onset’’, with speciﬁc keywords relating to the type of
the diverse risk factors of interest (eTable 1), and reﬁned by the
topic ‘‘research’’ in the Web of KnowledgeSM database. Second, a
manual search of the reference lists of retrieved articles was
performed. The abstracts of the articles identiﬁed through these
two steps were then screened in relation to the selection criteria.
The full text of the remaining articles were then assessed for
eligibility, following the MOOSE checklist (eTable 2) [22].
2.2. Selection criteria
Studies were eligible for inclusion when the following criteria
were fulﬁlled:
 an original article, written in English;
 inclusion of UHR individuals, deﬁned according to established
international criteria (i.e. Comprehensive Assessment of At Risk
Mental State [CAARMS]; Brief Psychiatric Rating Scale [BPRS];
Structured Interview for Psychosis-Risk Syndrome [SIPS]; Basel
Screening Instrument for Psychosis [BSIP]) [23–25];
 inclusion of a comparison group of controls (healthy or UHR or
local general population);
 cohort studies and case-control studies (in line with previous
meta-analyses of risk factors [26]) investigating risk factors in
UHR individuals as part of the primary or secondary study’s
aims;
 reported sufﬁcient meta-analytical data to perform the statisti-
cal analyses. When data were not available, the corresponding
author was contacted and invited to send additional informa-
tion.
Exclusion criteria were:
 abstracts, pilot datasets and manuscripts in languages other
than English;
 studies that did not employ internationally validated deﬁnitions
for UHR;
 studies acknowledging that their datasets were completely
included in other larger samples;
 Randomized Controlled Trials;
 studies that did not investigate risk factors in UHR samples as
part of the primary or secondary study’s aims;
 studies that could not provide meta-analytical data;
 studies addressing biomarkers of psychosis.
The literature search was summarized according to the PRISMA
guidelines [27].
2.3. Deﬁnition of risk factors
Because the ARMS predicts psychosis but not non-psychotic
disorders [16], we focused only on the association between risk
factors for psychosis and the ARMS, compared to controls.
According to the WHO, a risk factor is any attribute, characteristic
or exposure of an individual that increases the likelihood of
developing a disease or injury [28]. Therefore, in our case, a risk
factor for psychosis should increase the likelihood of developing
psychosis. Accordingly, the risk factors for psychosis considered in
the present manuscript were identiﬁed on the basis of previous
published evidence showing a signiﬁcant association with esta-
blished psychotic disorders (i.e. the 95% CIs of association measures
should not include 1). A qualitative summary table of association
measures for each risk factor considered in the current review was
produced for descriptive purposes. Two additional methodological
considerations relate to the nature and exposure to risk factors in
UHR individuals. First, although risk factors can be either causal or
correlational, pathophysiology of psychosis is unknown and there
are no causal risk factors as such. Consequently, all the included risk
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factors are correlational. Second, exposure to risk factors was
checked against a reference index, which was the time of the ﬁrst
UHR diagnosis. However, temporality is impossible to deﬁne with
certainty in case-control or cross-sectional designs of later and
antecedents risk factors. Therefore, it is possible that some of the
later and antecedents risk factors may actually represent baseline
characteristics of the UHR state. We included both genetic and
environmental risk factors of psychosis. The environmental risk
factors were clustered as previously described [29–32]: sociode-
mographic and familiar risk factors, prenatal/perinatal risk factors,
later risk factors and antecedents. Biomarkers (e.g. neurocognitive
markers) were not included as exposure is undetermined and
because these have been reviewed elsewhere [33,34].
2.4. Recorded variables
Data extraction was independently performed by two investi-
gators (SDS, MT). To estimate the primary outcome variable, we
extracted the number of cases and non-cases across UHR and
comparison groups (controls, C). When this data was not available
(e.g in case of continuous risk factors), we extracted the mean value
and standard deviation (SD) of the risk factor of interest across
cases and non-cases. To estimate the impact of potential
confounders, we further collected the following variables: type
of UHR psychometric instrument, age, sex, year of publication and
quality of study. Quality assessment was performed with an
adapted version of the Newcastle-Ottawa Scale (NOS) for the
evaluation of non-randomized studies. This tool has been adopted
in recent meta-analyses [35].
2.5. Systematic review
The studies were systematically discussed across each risk
factor domain as described above.
2.6. Meta-analysis
The primary purpose of the meta-analysis was to quantitatively
determine if there was an association between genetic and/or
environmental risk factors of psychosis and the UHR state. The
main effect size measure was the odds ratio (OR), which was
estimated through the number of cases and non-cases across UHR
and healthy controls (HC). When raw counts of cases and non-
cases across UHR or HC were not available (e.g. continuous risk
factors), we used the mean value and the SD of each risk factor in
each group. These were transformed into OR with the method
described by Hasselblad and Hedges [36]. Meta-analysis was
performed with the ‘‘metan’’ [37] function in Stata. Heterogeneity
among study point estimates was assessed using Q statistics with
the proportion of the total variability in the effect size estimates
being evaluated with the I2 index [38], which does not depend
upon the number of studies included. As meta-analysis of
observational studies is supposed to be characterized by signiﬁ-
cant heterogeneity, the DerSimonian and Laird random-effects
models were used [37]. Publication biases were assessed with the
‘‘metafunnel’’ function of Stata which produced funnel plots for
assessing small-study reporting bias in meta-analysis [39] and
with the ‘‘metatrim’’ [40] function of Stata. In the case of more than
two studies per group, we further performed the Egger test to
estimate publication biases with the ‘‘metabias’’ function of Stata
[41]. The impact of quality of studies (NOS) on meta-analytical
estimates was assessed using meta-regression analyses with the
‘‘metareg’’ [42] function of Stata. The meta-regressions were
conducted when at least 10 studies were available for each risk
factor [43]. In the case of signiﬁcant meta-analytical ﬁndings
not affected by publication biases, sensitivity analyses were
additionally conducted to investigate the robustness of the results.
The inﬂuence of each single study on the overall meta-analytical
estimates was investigated by omitting one study at a time, using
Stata’s user-written function, ‘‘metaninf’’ [44,45].
3. Results
3.1. Database
The initial literature search (PRISMA Fig. 1) uncovered
44 independent articles, comprising a total of 170 independent
datasets that were grouped into 54 risk factors. There were
18 studies employing the CAARMS, 25 employing the SIPS/SOPS,
one employing the BPRS and one employing the BSIP. The mean age
of the patients and controls was 21.4 years and 21.9 years,
respectively. With the exception of four studies using UHR
samples [46–49], all the other studies recruited healthy controls as
comparison group. The type of risk factor, risk factor domain,
sample size, type of UHR psychometric instrument are detailed in
Table 1. Independent evidence that each of these risk factors is
signiﬁcantly associated with an increased risk of psychosis is
qualitatively summarized in the eTable 3.
3.2. Systematic review
Results of the systematic review are appended supplementary
in the eResults section.
3.3. Meta-analysis
3.3.1. Study selection for the meta-analysis
There were not enough studies (i.e. less than 2 studies) to
perform a meta-analysis of the following risk factors: gestational
age < 37 weeks, birth weight < 2000 g, birth weight < 2500 g,
breech presentation, cord knotted or around neck,
incubator > 4 weeks, ethnic minorities, perceived ethnic discrimi-
nation, traumatic brain injuries, barbiturates use, ecstasy use,
novelty seeking, harm avoidance, reward dependence, persistence,
self-directness, cooperativeness, self-transcendence and family
history of non-psychotic disorders (Table 2). For comprehensive-
ness, we reported the OR of these single studies along with their
95% CI.
3.3.2. Environmental risk factors for psychosis in UHR samples
3.3.2.1. Prenatal/perinatal risk factors. There was meta-analytical
evidence for a signiﬁcant association between unspeciﬁed obstet-
ric complications and the UHR state (OR = 3.06). No signiﬁcant
association was observed for maternal tobacco smoking, alcohol,
aspeciﬁc drug use and caesarean delivery.
3.3.2.2. Later risk factors and antecedents. There was meta-
analytical evidence for a signiﬁcant association between tobacco
use and the UHR state (OR = 3.04). There was also meta-
analytical evidence that the UHR individuals were less likely
to use alcohol than controls (OR = 0.65) and more likely to be
physically inactive (OR = 3.54). There was strong meta-analytical
evidence that aspeciﬁc childhood trauma was associated with
the UHR state (OR = 5.94) as well as childhood emotional abuse
(OR = 5.84), childhood physical neglect (OR = 3.07) and high
perceived stress (OR = 4.71). General childhood low functioning
(OR = 6.1), early adolescent low functioning (OR = 5.7) and late
adolescent low functioning (OR = 6.46) were strongly associated
with the UHR state. Social deﬁcits (OR = 9.71) and affective
comorbidities (OR = 9.56) appeared strongly associated with the
UHR state, but there were signiﬁcant publication biases (see
below).
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There was no meta-analytical evidence that cannabis, cocaine,
amphetamine, opiates, hallucinogens use, 1st or 2nd generation
migrant status, childhood sexual abuse, childhood physical abuse,
childhood emotional neglect, adverse life events, childhood
bullying were associated with the UHR state.
3.3.2.3. Sociodemographic and familiar risk factors. There was meta-
analytical evidence that male gender (OR = 1.38), single status
(OR = 1.64), unemployment (OR = 1.53) and low educational level
(OR = 1.47) were associated with the UHR state. Conversely, there
was no meta-analytical evidence that the UHR samples were more
likely to be of black ethnicity or to have a low parental
socioeconomic status.
3.3.3. Publication bias
There were indications of publication biases with respect to
social deﬁcits (Egger = 0.060) and presence of affective comorbi-
dities (Egger = 0.018). The trim and ﬁll method adjusted meta-
analytical estimate for social deﬁcits was non-signiﬁcant 0.413
(95% CI 0.001–1.439), while it survived for affective comorbidities:
1.371 (95% CI 1.014–2.264). There were no publication biases for
the other risk factors associated with the UHR state.
3.3.4. Quality assessment
Quality assessment with the NOS is appended in the supple-
mentary eTable 4. Meta-regression analyses showed no impact of
NOS on OR estimates of social deﬁcits (b = 0.069, SE = 0.407, 95%
CI 0.950–0.811, P = 0.867), affective comorbidities (b = 0.291,
SE = 0.392, 95% CI 0.614–1.117, P = 0.479), male gender
(b = 0.0818, SE = 0.101, 95% CI 0.127–0.292, P = 0.426), black
ethnicity (b = 0.145, SE = 0.144, 95% CI 0.187–0.478, P = 0.342).
3.3.5. Sensitivity analyses
Sensitivity analyses of meta-analytical estimates uncovered no
outliers and conﬁrmed the robustness of the results.
4. Discussion
This is the ﬁrst systematic review to comprehensively explore
why UHR individuals have an enhanced vulnerability to psychosis
compared to matched controls (RR = 460), by investigating the
association between established genetic and environmental risk
factors for psychosis and the UHR state. We found 44 studies and a
total of 170 independent datasets investigating risk factors for
psychosis in UHR individuals. There were no studies reporting on
genetic risk factors for psychosis in UHR subjects that fulﬁlled our
inclusion criteria. There was substantial research into sociodemo-
graphic risk factors for psychosis and to a lesser extent into later
risk factors and antecedents, while data on prenatal/perinatal risk
factors were relatively scarce. The meta-analysis indicated that
UHR individuals were more likely to experience obstetric
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Table 1
Studies included in the systematic review.
Author Research centre UHR
deﬁnition
Type of risk factor UHR
sample
C sample
Reininghaus et al., 2016 [77] London, OASIS CAARMS Unemployment (Medical Research Council sociodemographic
schedule, modiﬁed), high perceived stress (ESM)
46 53
Shaikh et al., 2016 [78] London, OASIS CAARMS Male gender, Black ethnicity, 1st generation migrant, 2nd
generation migrant, perceived ethnic discrimination (PEDQ-CV)
64 43
Papmeyer et al., 2016 [21] Basel, FePsy BSIP Male gender, single status, low educational level, childhood
trauma (BIP), childhood bullying (BIP), social deﬁcits (BIP)
127 28
Stowkowy et al., 2016 [19] Multicenter, NAPLS-2 SIPS Male gender, low educational level, childhood trauma (CTQ),
childhood bullying (CTQ)
764 280
Deighton et al., 2016 [79] Multicenter, NAPLS-2 SIPS Traumatic brain injury (TBI) 747 278
Palmier-Claus et al., 2016 [20] Manchester CAARMS Male gender, black ethnicity, childhood trauma (CTQ), social
deﬁcits (PSP), affective comorbidities (CDS)
14 120
Masillo et al., 2016 [49] Rome, Release the Future
Project
SIPS Male gender, unemployment, social deﬁcits (GFS) 39 108
Bentley et al., 2016 [47] Multicenter, Strive for
Wellness/Youth
FIRST research program
SIPS Male gender, black ethnicity, affective comorbidities (K-SADS-PL),
high perceived stress (BASC-2)
36 60
Thompson et al., 2015 [48] Multicenter, Strive for
Wellness/Youth
FIRST research program
SIPS Social deﬁcits (BASC-2) 35 55
O’Donoghue et al., 2015 [80] PACE clinic, Melbourne CAARMS Social deﬁcits (SEIFA) 166 131,790
Valmaggia et al., 2015 [81] London, OASIS CAARMS High perceived stress (DASS), affective comorbidities (DASS) 64 43
Buchy et al., 2015 [82] Multicenter, NAPLS-2 SIPS Black ethnicity, tobacco (AUS/DUS), cannabis (AUS/DUS), alcohol
(AUS/DUS), cocaine (AUS/DUS), amphetamines (AUS/DUS),
opiates (AUS/DUS), hallucinogens (AUS/DUS)
735 278
Deighton et al., 2015 [83] Multicenter, NAPLS-2 SIPS Physical inactivity (IPAQ) 40 40
Kirkbride et al., 2015 [84] Cambridgeshire, PAATH CAARMS Low parental socioeconomic status (Census 2011), ethnic minority
(Census 2011)
48 41
Valmaggia et al., 2015 [85] London, OASIS CAARMS Unemployment (Census 2001), low parental socioeconomic status
(Census 2001), childhood bullying (RBQ)
64 43
Welsh et Tifﬁn, 2015 [86] North East England, NHS
Mental Health Trust
CAARMS Male gender, social deﬁcits (FPS) 44 140
Kotlicka-Antczak et al., 2014 [87] Lodz, Early Psychosis
Diagnosing and Treatment
Center
CAARMS Male gender, unspeciﬁed obstetric complications (CHB + MLCOS),
gestational age < 37 w (CHB + MLCOS), maternal tobacco smoking
(CHB + MLCOS), maternal drug use, maternal alcohol use, birth
weight < 2000 g (CHB + MLCOS), birth weight < 2500 g
(CHB + MLCOS), caesarean delivery, complicated or emergency
(CHB + MLCOS), Breech or abnormal presentation (CHB + MLCOS),
Cord knotted or around neck (CHB + MLCOS), incubator > 4 weeks
(CHB + MLCOS)
66 50
Simeonova et al., 2014 [88] Atlanta, Emory University SOPS Male gender, childhood low functioning (CBCL) 53 32
Russo et al., 2014 [89] Cambridgeshire, PAATH CAARMS Male gender, unemployment, black ethnicity, adverse life events
(THS)
60 60
Russo et al., 2014 [90] Cambridgeshire, PAATH CAARMS Cannabis (face to face interview), alcohol (face to face interview),
opiates (face to face interview), hallucinogens (face to face
interview)
60 60
Stowkowy et Addington, 2013 [91] Multicenter, NAPLS-2 SIPS Single status, 1st generation migrant, 2nd generation migrant,
childhood low functioning (PAS), early adolescent low functioning
(PAS), late adolescent low functioning (PAS)
25 25
Tikka et al., 2013 [55] Turku, DEEP SIPS/SOPS Male gender, single status, unemployment, low educational level,
childhood sexual abuse (TADS), childhood physical abuse (TADS),
childhood emotional abuse (TADS), childhood emotional neglect
(TADS), childhood physical neglect (TADS), childhood low
functioning (PAS), early low adolescent functioning (PAS), late low
adolescent functioning (PAS)
20 30
DeVylder et al., 2013 [92] New York, COPE SIPS Male gender, black ethnicity, unemployment, cannabis, alcohol,
adverse life events (Coddington’s life events record), affective
comorbidities (BDI)
65 24
Hui et al., 2013 [93] Cambridgeshire, CAMEO CAARMS Single status, social deﬁcits, affective comorbidities-depression
(BDI-II), affective comorbidities-mania (YMRS)
60 45
Jalbrzikowski et al., 2013 [94] Multicenter, NAPLS SIPS Low parental socioeconomic status 61 36
Mittal et al., 2013 [95] Colorado, ADAPT SIPS Male gender, low parental socioeconomic status, physical
inactivity (ActiGraph Monitor)
29 27
S¸ ahin et al., 2013 [96] Istanbul, Psychiatric
Disorder Research
Program
BPRS Male gender, childhood sexual abuse (CTQ), childhood physical
abuse (CTQ), childhood emotional abuse (CTQ), childhood
emotional neglect (CTQ), childhood physical neglect (CTQ)
41 69
Song et al., 2013 [97] Seoul, GRAPE Project SIPS Male gender, low educational level, novelty seeking (TCI/JTCI),
harm avoidance (TCI/JTCI), reward dependence (TCI/JTCI),
persistence (TCI/JTCI), self-directedness (TCI/JTCI),
cooperativeness (TCI/JTCI), self-transcendence (TCI/JTCI)
50 120
Schlosser et al., 2012 [98] Los Angeles, CAPPS SIPS Male gender, black ethnicity, social deﬁcits (GF: social) 84 58
Auther et al., 2012 [99] New York, RAP SOPS Tobacco (KSADS-E), cannabis (KSADS-E), alcohol (KSADS-E),
cocaine (KSADS-E), amphetamines (KSADS-E), barbiturates
(KSADS-E), opiates (KSADS-E), hallucinogens (KSADS-E), ecstasy
(KSADS-E)
101 59
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complications, use tobacco, have physical inactivity, childhood
trauma/emotional abuse/physical neglect, high perceived stress,
childhood and adolescent low functioning, affective comorbidities,
be of male gender, single status, unemployment and have low
educational level as compared to controls.
First, our systematic review uncovered no studies investigating
the association of genetic risk factors of psychosis and the UHR
state. This is surprising, given that the genetic and deterioration
syndrome (GRD) subgroup is one of the three core inclusion criteria
deﬁning an UHR state [23]. However, the lack of research for
prominent genetic risk factors in UHR samples is in line with recent
evidence suggesting that in UHR subjects trait risk factors are of
less clinical relevance than state risk factors. For example, a recent
meta-analysis has shown that the GRD subgroup is not actually
indexing an enhanced vulnerability for psychosis, with only
modest transitions risks of 5% at 3 years follow-up that were
comparable to the control group [3]. The GRD construct also lacks
epidemiological validation (prevalence for the APS and BLIPS
subgroups but not GRD has been reported in the general
population [50]). Research into genetic risk factors of psychosis
in this ﬁeld may be further hindered by small statistical power
associated with the low frequency of the GRD subgroup, which
accounts for only 5% of the UHR cases at intake [3]. Conversely, the
BLIPS subgroup expressing extreme state risk factors (as opposed
to genetic trait factors characterizing the GRD) for psychosis [51]
displays a distinctive prognosis with higher transition risks (e.g.
39% vs 19% at 24 months) compared to the APS and GRD subgroups
[3]. On the basis of the available evidence, it is therefore possible to
conclude that UHR samples have an increased vulnerability for
psychosis mostly because of state risk factors that are associated
with environmental exposures, the role of genetic (and epigenetic)
risk factors awaiting elucidation.
Second, our systematic review, reﬁned by quantitative synthe-
sis, has identiﬁed a set of speciﬁc risk factors for psychosis that may
be associated with an increased vulnerability in UHR individuals.
For example, although research into prenatal/perinatal risk factors
among UHR subjects is still in its infancy, we found that UHR
individuals were more likely to have had general obstetric
complications as compared to controls (OR = 3.06). Perinatal
insults have been consistently associated with psychotic disorders
(eTable 3); they may impact brain developmental processes
including neurogenesis, neuronal proliferation and migration,
synaptogenesis, gliogenesis and subcortical myelination, and may
represent the ﬁrst-wave hits for the onset and progression of
psychosis (see Fig. 2 below here [52]). Although the most
compelling potential interventions to prevent psychosis currently
address the UHR state, which usually identify subjects in the
2 years preceding a ﬁrst episode of psychosis, perinatal preventa-
tive treatments are on the horizon. For example, perinatal dietary
supplementation with phosphatidylcholine in healthy pregnant
women, starting in the second trimester, ameliorates electrophys-
iological biomarkers of psychosis in infants at 13 weeks [53].
Table 1 (Continued )
Author Research centre UHR
deﬁnition
Type of risk factor UHR
sample
C sample
Palmier-Claus et al., 2012 [100] Manchester CAARMS Black ethnicity, high perceived stress (PSS) 27 27
Chudleigh et al., 2011 [101] Sydney, Youth Mental
Health Clinic
CAARMS Male gender, affective comorbidities (DASS) 20 20
Pruessner et al., 2011 [102] Montreal, PEPP-Montreal CAARMS Male gender, single status, tobacco, cannabis, high perceived
stress (TICS)
30 30
Carrion et al., 2011 [103] New York, RAP SOPS Male gender, black ethnicity, low educational level, low parental
socioeconomic status (Hollingshead and Redilich), social deﬁcits
(GFS)
127 80
Jang et al., 2011 [104] Seoul, SYC CAARMS Male gender, low educational level, social deﬁcits (SFS) 57 58
Stanford et al., 2011 [105] New York, COPE SIPS/SOPS Social deﬁcits (SAS-SR) 63 24
Fusar-Poli et al., 2010 [73] London, OASIS CAARMS Social deﬁcits (Census 2001), unemployment (Census 2001) 152 98,072
Woods et al., 2009 [106] Multicenter, NAPLS SIPS Familial history of nonpsychotic mental disorders (Family history-
research diagnostic criteria data sheet, FIGS, local structured
measures)
377 196
Niendam et al., 2009 [107] Los Angeles, CAPPS SIPS Low educational level, affective comorbidities (BPRS), social
deﬁcits (GFS)
64 26
Ballon et al., 2008 [108] San Diego, CARE SIPS Unspeciﬁed obstetric complications (MLOCS), maternal tobacco
smoking (not speciﬁed), maternal drug use (not speciﬁed),
maternal alcohol use (not speciﬁed), caesarean delivery,
complicated or emergency (MLOCS)
52 43
Shim et al., 2008 [109] Seoul, SYC CAARMS Unemployment 32 30
Ballon et al., 2007 [110] San Diego, CARE SIPS Male gender, social deﬁcits (SAICA) 33 34
San Diego, CARE SIPS Male gender, social deﬁcits (SAS-SR) 22 11
Rosen et al., 2006 [46] New Haven, PRIME SIPS Male gender, black ethnicity, affective comorbidities (SCID-I/P) 29 29
Svirskis et al., 2005 [111] Turku, DEEP SIPS Affective comorbidities (SCID I) 39 77
ADAPT: Adolescent Development and Preventive Treatment research program; AUS/DUS: Alcohol and Drug Use Scale; BASC-2: Behaviour Assessment System for Children:
Second Edition; BDI: Beck Depression Inventory; BDI-II: Beck Depression Inventory: version II; BIP: Basel Interview for Psychosis; BPRS: Brief Psychiatric Rating Scale; BSIP:
Basel Screening Instrument for Psychosis; CAARMS: Comprehensive Assessment of At-Risk Mental State; CAPPS: Staglin Music Festival Center for the Assessment and
Prevention of Prodromal States; CARE: Cognitive Assessment and Risk Evaluation Program; CBCL: Child Behaviour Checklist; CDS: Calgary Depression Scale; CHB: Child’s
Health Book; COPE: Center of Prevention and Evaluation; CTQ: Childhood Trauma Questionnaire; DASS: Depression, Anxiety and Stress Scale; DEEP: Detection of Early
Psychosis Project; ESM: Experience Sampling Method; FePsy: Fruherkennung von Psychosen; FIGS: Family Interview for Genetic Studies; FPS: Family Perceptions Scale; GFS:
Global Functioning Social Scale; GF: Global Functioning Scale: social; GRAPE: Green Programme for Recognition and Prevention of Early Psychosis; IPAQ: International
Physical Activity Questionnaire; JTCI: Junior Temperament and Character Inventory; KSADS-E: Kiddie Schedule for Affective Disorders and Schizophrenia – Epidemiologic
Version; K-SADS-PL: Kiddie Schedule for Affective Disorders and Schizophrenia: Present and Lifetime Version; MLCOS: Murray-Lewis Obstetric Complications Scale; NAPLS:
North American Prodrome Longitudinal Study; NAPLS-2: North American Prodrome Longitudinal Study 2; OASIS: Outreach and Support in South London; PAATH: Prospective
Analysis of At-Risk-Mental-States and Transitions into PsycHosis; PAS: Cannon-Spoor Premorbid Adjustment Scale; PEDQ-CV: Perceived Ethnic Discrimination
Questionnaire-Community Version; PEPP-Montreal: Prevention and Early Intervention Program for Psychoses; PSP: Personal and Social Performance Scale; PSS: Perceived
Stress Scale; RAP: Recognition and Prevention; RBQ: Retrospective Bullying Questionnaire; SAICA: Social Adjustment Inventory for Children and Adolescent; SAS-SR: Social
Adjustment Scale – Self Rated; SCID-I/P: DSM-IV Axis I disorders – patient edition; SEIFA: Socioeconomic Indexes for Areas; SFS: Social Functioning Scale; SIPS: Structured
Interview for Prodromal Syndromes; SOPS: Scale of Prodromal Symptoms; SYC: Seoul Youth Clinic; TADS: Trauma and Distress Scale; TBI: Traumatic Brain Injury Interview;
TCI: Temperament and Character Inventory; THS: Trauma History Screen; TICS: Trier Inventory for the Assessment of Chronic Stress.
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Our review further showed that second-wave hits occurring
during childhood and adolescence of UHR samples were relatively
more investigated, including traumatic events (childhood trauma/
emotional abuse/physical neglect, high perceived stress) and low
childhood and adolescent functioning (general childhood, early
and late adolescent low functioning). All of these factors have been
consistently associated with an increased risk of psychotic
disorders (eTable 3). The magnitude of association between
traumatic events and the UHR was strong, with meta-analytical
ORs of up to 5.9 (Table 2). A previous meta-analysis investigating
the prevalence of childhood trauma in UHR individuals conﬁrmed
a high mean prevalence rate of 86.8% (95% CI 77%–93%)
[54]. Traumatic events are thus highly prevalent and strongly
associated with the UHR state as compared to controls, impacting
on the severity of attenuated psychotic symptoms [55]. A recent
study showed that traumatic events additionally impact the
functional level of UHR subjects [56]. In line with this ﬁnding, we
found that UHR individuals were more likely to be functionally
Table 2
Meta-analytical evidence for the association of environmental risk factors for psychosis and the UHR state. When a single study per group is available, the individual effect size
is reported for descriptive purposes. There was no assumption that these risk factors were of causal nature or that they all are independent from each other.
Domain Psychosis risk factor Number of
studies
N UHR N
C
OR 95% CI P I2 P (I2) (%)
Prenatal/perinatal
risk factors
Complications
of pregnancy
Gestational age < 37 1 65 50 0.733 0.43 1.248 0.253
Maternal tobacco smoking 2 118 93 2.081 0.629 6.89 0.23 0 0.833
Maternal drug use 2 118 93 1.195 0.09 17.798 0.892 0 0.764
Maternal alcohol use 2 118 93 2.084 0.194 22.349 0.544 46.20 0.173
Obstetric
complications
Birth weight < 2000 g 1 66 50 0.369 0.033 4.187 0.421
Birth weight < 2500 g 1 66 50 1.531 0.135 17.366 0.731
Caesarean delivery 2 118 93 1.55 0.341 7.043 0.57 61.50 0.107
Breech or abnormal presentation 1 66 50 2.33 0.236 23.106 0.469
Cord knotted or around neck 1 66 50 1.859 0.458 7.549 0.386
Incubator > 4 weeks 1 66 50 0.754 0.046 12.348 0.843
Unspeciﬁed obstetric complications 2 118 93 3.062 1.813 5.171 < 0.001 0 0.585
Later risk factors
and antecedents
Ethnosocial group Ethnic minority 1 48 41 1.28 1 1.639 0.05
1st generation migrants 2 89 68 0.453 0.198 1.039 0.062 0 0.450
2nd generation migrants 2 89 68 1.271 0.513 3.152 0.604 0 0.388
Perceived ethnic discrimination 1 64 43 8.463 2.139 33.457 0.002
Physical
conditions
Traumatic brain injury 1 747 278 1.827 1.32 2.527 < 0.001
Physical inactivity 2 69 67 3.547 1.694 7.425 0.001 0 0.327
Substance abuse Tobacco 3 866 367 3.043 1.204 7.692 0.019 64.10 0.062
Cannabis 5 991 451 1.786 0.785 4.065 0.167 76.80 0.002
Alcohol 4 961 421 0.645 0.463 0.9 0.01 30.10 0.232
Cocaine 2 765 308 2.533 0.613 10.457 0.199 0 0.486
Amphetamines 2 836 337 3.438 0.419 28.218 0.25 0 0.706
Barbiturates 1 101 59 3.806 0.187 77.331 0.384
Opiates 3 896 397 3.983 0.676 23.454 0.127 0 0.691
Hallucinogens 3 896 397 1.958 0.578 6.628 0.28 36.60 0.207
Ecstasy 1 101 59 1.871 0.19 18.407 0.591
Trauma/adversity Childhood trauma 3 905 428 5.943 2.896 12.199 < 0.001 41.60 0.181
Childhood sexual abuse 2 61 99 1.847 0.641 5.323 0.256 0 0.66
Childhood physical abuse 2 61 99 2.191 0.686 6.99 0.186 11.80 0.287
Childhood emotional abuse 2 61 99 5.843 1.794 19.027 0.003 7.80 0.298
Childhood emotional neglect 2 61 99 7.221 0.894 58.308 0.064 63.70 0.097
Childhood physical neglect 2 61 99 3.066 1.043 9.013 0.042 0 0.411
Childhood bullying 3 955 351 2.322 0.861 6.263 0.096 89.10 < 0.001
Adverse life events 2 125 84 1.249 0.719 2.171 0.430 3 0.310
High perceived stress 5 203 213 4.71 1.987 11.166 < 0.001 37.00 0.175
Functioning Childhood low functioning 3 98 87 6.100 2.183 17.047 0.001 0 0.741
Early adolescent low functioning 2 45 55 5.7 1.4 23.29 0.015 0 0.355
Late adolescent low functioning 2 45 55 6.46 1.58 26.45 0.009 0 0.955
Social deﬁcits 15 1065 230638 9.709 3.819 24.681 < 0.001a 92 < 0.001
Psychiatric
comorbidities
Affective comorbidities 10 391 444 9.555 3.969 23.003 < 0.001b 80.1 < 0.001
Personality traits Novelty seeking 1 50 120 0.572 0.192 1.702 0.315
Harm avoidance 1 50 120 11.134 3.415 36.297 < 0.001
Reward dependence 1 50 120 0.112 0.035 0.358 < 0.001
Persistence 1 50 120 0.219 0.071 0.673 0.008
Self-directedness 1 50 120 0.129 0.041 0.409 0.001
Cooperativeness 1 50 120 0.321 0.106 0.972 0.044
Self-transcendence 1 50 120 0.703 0.237 2.084 0.525
Sociodemographic
and familiar
risk factors
Sociodemographic
risk factors
Male gender 23 1852 1500 1.381 1.147 1.663 0.001 43.6 0.014
Single status 5 262 158 1.637 1.136 2.359 0.008 16.40 0.31
Unemployment 8 478 98,420 2.828 1.526 5.243 0.001 70.70 0.001
Black ethnicity 10 1241 779 0.943 0.725 1.227 0.665 0 0.899
Low educational level 7 1209 622 1.466 1.047 2.053 0.026 0 0.616
Familiar risk
factors
Family history of
non-psychotic disorders
1 377 196 5.118 3.32 7.887 < 0.001
Low parental socio-economic
status
5 329 277 1.173 0.583 2.358 0.654 61.90 0.033
In bold, signiﬁcant meta-analytical results corrected for potential publication biases.
a Adjusted OR for publication biases: 0.413 (95% CI 0.001–1.439).
b Adjusted OR for publication biases: 1.371 (95% CI 1.014–2.264).
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impaired during their early and late adolescence. The magnitude of
the effect size was the strongest across all risk factors examined in
our analysis (5.7 to 6.4, see Table 2). The ﬁnding of an impaired
functional level in the UHR state is not novel and it is an established
marker of the condition as well of its longitudinal course [57]. The
current review adds on these previous ﬁndings by showing that an
early functional impairment during adolescence may represent a
consistent second-wave hit for the constitution of an UHR state, in
line with studies showing that functional impairment can precede
psychosis by about 15 years [58]. Traumatic events and low
adolescent functioning may be clinically associated with the
development of affective dysregulation and mood comorbidities.
Indeed, we conﬁrmed the previous prevalence ﬁnding of high rates
of depressive and anxiety disorders in UHR subjects [59]. These
ﬁndings are in line with the theory of an affective pathway to
psychosis after exposure to traumatic events, with mood
symptoms as a main connective component [60]. From a
psychopathological perspective, affective dysregulation lies at
the heart of psychosis onset and may be associated with the
neurobiological alterations observed in UHR individuals [61].
In contrast, we found no convincing evidence that the UHR state
was associated with illicit substance use. UHR subjects were more
likely to use tobacco and less likely to use alcohol than controls.
The impact of tobacco use as a risk factor for psychosis is an
emerging theme (as it is physical inactivity) [62] and it is less
established than other traditional risk factors [63] (eTable 3). Our
systematic review found no evidence that UHR subjects were more
likely to use cannabis than controls, in line with studies indicating
that cannabis use or cannabis use disorders are not related to more
severe attenuated positive psychotic symptoms at baseline
[64]. There is speciﬁc evidence that the lack of association between
cannabis misuse and transition to psychosis in UHR samples might
be confounded by alcohol use [64]. Owing to the observed
interaction between alcohol and cannabis abuse and to small to
medium sample size of these meta-analyses, these ﬁndings should
be interpreted cautiously and further research on these risk factors
is needed.
Among sociodemographic and familial risk factors, we found
that UHR individuals were more likely to be male than controls.
Male gender has been consistently associated with an increased
risk of psychosis [12] (eTable 3). Within the UHR population, it has
been reported that males are more likely to have poorer baseline
functioning [65] and that poorer baseline functioning predicts later
transitions in males [66]. The male gender has also been associated
with a prolonged duration of untreated UHR symptoms [67], which
in turn is associated with higher risk of transition [68]. Additional
evidence linking male gender and vulnerability to psychosis in
UHR samples comes from meta-analyses suggesting that changes
in the proportion of males accessing UHR services may contribute
to the declining transition risks observed over the recent years
[69]. We further found that UHR individuals were more likely to be
single, unemployed and with low educational levels as compared
to controls, all established risk factors for psychosis (eTable 3).
Marital status is a signiﬁcant protective factor for health related
outcomes in several physical conditions (including severe dis-
orders such cancer) [70], and single status has been speciﬁcally
associated with an increased risk of psychosis [71] and with social
dysfunction in schizophrenic patients [72]. Similarly, unemployed
status and low educational level have been shown to be associated
with an increased risk of psychosis, in particular in males
[71]. There is also speciﬁc evidence for unemployment to predict
psychosis onset within UHR samples [73]. Overall, these results
suggest a potential pathological association between negative
social factors and an increased vulnerability to psychosis. These
negative social factors are also likely to reﬂect the impact of
accumulating traumatic events in UHR individuals, which in turn
Fig. 2. Putative model of the onset and progression of psychosis in relation to risk factors and developmental processes affected by the disorder. The diagnosis of psychosis,
which operationally corresponds to the ﬁrst episode of psychosis, is usually made in young adults. Diagnosis generally follows an UHR phase in which attenuated psychotic
symptoms, functional impairment and help-seeking behavior are apparent. Once diagnosed, psychosis follows a ﬂuctuating course punctuated by acute exacerbation of
psychotic crises superimposed upon a background of poorly controlled negative, neurocognitive and social cognitive symptoms. Many environmental risk factors have been
incriminated during both the perinatal (ﬁrst wave) period and during adolescence (second wave), on top of baseline genetic load. Throughout the disorder, additional adverse
environmental events can trigger crises (booster hits). The pink boxes represent the putative risk factors for psychosis associated with an UHR state as identiﬁed by our
systematic review and meta-analysis. There was no assumption that these risk factors were of causal nature or that they all are independent from each other. Furthermore,
certain second-wave hits may actually represent outcomes of ﬁrst-wave hits (blue arrows).
Adapted from [52].
P. Fusar-Poli et al. / European Psychiatry 40 (2017) 65–7572
may lead to mood dysregulation and affective comorbidities, as
tentatively illustrated in Fig. 2.
These assumptions, however, remain speculative, as our
study is not designed to investigate causal interactions between
different environmental risk factors for psychosis. As we have
acknowledged for the deﬁnition of risk factors, association does
not necessarily imply causation and because the pathophysiol-
ogy of psychosis is unknown, there are no causal risk factors for
psychosis as such. Temporality is also impossible to deﬁne with
certainty in case-control or cross-sectional designs but they
have the advantage of examining remote exposures and have
been used in previous meta-analyses of risk factors for medical
conditions [74]. The evidence that each risk factor considered in
the current meta-analysis is actually increasing the likelihood of
psychosis is therefore based on previous evidence published in
patients with a frank psychotic disorder (eTable 3). Furthermore,
large-scale prospective cohort studies of epidemiological validi-
ty are not feasible in this ﬁeld because UHR samples are deﬁned
not only by the UHR criteria but also by heterogeneous and
idiosyncratic recruitment procedures that are not easily
replicable [75]. At the same time, the use of UHR instruments
in other non help-seeking samples in the general population is
not informative, yielding minimal transition risks that are likely
to reﬂect a different underlying composition of risk factors for
psychosis [2]. Another limitation is that our review focused only
on well-known risk factors associated with psychosis. Therefore,
we cannot exclude that there may be additional different risk
factors that are speciﬁcally associated with an ARMS but not
with established psychosis. It is also possible that the risk
factors for psychosis identiﬁed at the univariate meta-analysis
may not be all independent and that some of them may actually
interact. Multivariable analyses in this database were not
possible because the data were too sparse. Also, because of
the lack of speciﬁc data, we were unable to address if
environmental risk factors for psychosis differed across UHR
subgroups (i.e. BLIPS vs GRD vs APS) or across UHR instruments
(i.e. CAARMS vs SIPS). Similarly, it is important to acknowledge
that some of the negative ﬁndings should be interpreted
cautiously, because the power of some meta-analyses (e.g.
migration status and bullying) was rather limited. In addition,
our primary aim was to deconstruct the enhanced vulnerability
to psychosis of UHR individuals (RR = 460), compared to
matched controls. Consequently, we did not speciﬁcally
investigate the association between potential risk factors and
the onset of psychosis within UHR samples. Reviewing
predictors of psychosis within UHR samples would require a
different methodological approach focused on predictive
models, which has been explored in a recent independent
study from our group [76].
5. Conclusion
The increased vulnerability of UHR subjects for psychosis can be
attributed to diverse environmental risk factors. Conversely, the
relevance of genetic (and epigenetic) risk factors for UHR subject
conversion to psychosis remains to be elucidated. UHR subjects are
more likely to show obstetric complications during the prenatal/
perinatal period. During childhood or adolescence, traumatic
events coupled with high-perceived stress may result in affective
dysregulation, low adolescent functioning and signiﬁcant affective
comorbidities. Sociodemographic risk factors such as male gender,
single status, unemployment and low educational level may
further accumulate in UHR individuals, accounting for their
enhanced risk of developing psychosis. These ﬁndings provide a
framework for further study of the possible relationship between
risk factors and UHR.
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